Clinical Trial

A Study of MI078 for Postpartum Depression

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, double-blind, placebo-controlled trial consisting of an experimental drug group and a placebo group, each enrolling 100 participants. The objective of this study is to assess the efficacy and safety of MI078 capsules for the treatment of postpartum depression.
Trial Details
NCT Number NCT07721961
Lead Sponsor Nanjing Minova Pharmaceutical Co., Ltd.
Conditions Postpartum Depression (PPD)
Enrollment 200 participants
Start Date 2026-07-10
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-23